MétaCan
Menu
Back to cohort
Record W4410955176 · doi:10.1001/jamaneurol.2025.1481

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome

2025· article· en· W4410955176 on OpenAlexfundno aff
Nicolás Fissolo, Sabine Schädelin, Luisa María Villar, Jan D. Lünemann, Jorge Correale, Konrad Rejdak, Nicholas Schwab, Andreu Vilaseca, Friederike Held, Antonio Garcı́a-Merino, Stefan Bittner, María Trojano, Roberto Furlan, Hayrettin Tumani, Francisco Pérez‐Miralles, Igal Rosenstein, Daniela Galimberti, Gary Álvarez-Bravo, Éric Thouvenot, Sara Llufriú, Samia J. Khoury, Robert Hoepner, Sergio Martínez‐Yélamos, Harald Hegen, Jelena Drulović, Neus Téllez-Lara, Michael Khalil, Johanna Oechtering, Ángel Pérez Sempere, Alfredo Rodríguez Antigüedad, José Enrique-Martínez, Eva Strijbis, Joep Killestein, Sara Eichau, Elena Colombo, Jonas Schaller-Nagengast, Luciana Midaglia, Antonio Sánchez, Enric Monreal, Andrew T. Chan, Friedemann Paul, Àlex Rovira, Mar Tintoré, Jan Lycke, Frauke Zipp, Bernhard Hemmer, Jens Kühle, Xavier Montalbán

Bibliographic record

VenueJAMA Neurology · 2025
Typearticle
Languageen
FieldMedicine
TopicMultiple Sclerosis Research Studies
Canadian institutionsnot available
FundersCilagNIH Clinical CenterSanofi GenzymeEMD SeronoCelgeneAmsterdam NeuroscienceChugai PharmaceuticalMedDay PharmaceuticalsIpsenMylanUniversitat Autònoma de BarcelonaNational Research FoundationUniversidad de AlcaláInstitut National de la Santé et de la Recherche MédicaleKarl-Franzens-Universität GrazDeutsche ForschungsgemeinschaftMultiple Sclerosis SocietyVrije Universiteit AmsterdamInternational Progressive MS AllianceHorizon TherapeuticsMedizinische Universität GrazUniversitätsmedizin GöttingenUniversitat de BarcelonaCentre National de la Recherche ScientifiqueMedizinische Universität InnsbruckEuropean CommissionInselspital, Universitätsspital BernSanofiTG TherapeuticsAmsterdam University Medical CentersUniversität InnsbruckBundesministerium für Bildung und ForschungMerck KGaAF. Hoffmann-La RocheAmerican University of BeirutUniversity of VictoriaHexal AGBiogenAlexion PharmaceuticalsNeuraxpharmBristol-Myers SquibbTeva Pharmaceutical IndustriesMassachusetts General HospitalUniversity of BernCSL BehringEli Lilly and CompanySamsungInstituto de Salud Carlos IIIAmgen
KeywordsMedicineHazard ratioInternal medicineProportional hazards modelMultiple sclerosisMagnetic resonance imagingClinically isolated syndromeCohortMcDonald criteriaGastroenterologyConfidence intervalImmunologyRadiology

Abstract

fetched live from OpenAlex

Importance: Understanding the risk factors for symptom development will allow clinicians to stratify people with radiologically isolated syndrome (pwRIS) more effectively and tailor their management strategies accordingly. Objective: To identify prognostic factors at radiologically isolated syndrome (RIS) diagnosis associated with the development of multiple sclerosis (MS) symptoms. Design, Setting, and Participants: This cohort study was performed in samples collected between July 2004 and September 2022 and included 33 MS centers. All pwRIS who meet the 2017 McDonald criteria for dissemination in space with a sample collected near the diagnostic magnetic resonance imaging were included. No patients who met eligibility criteria were excluded. The data were analyzed from July 2024 to November 2024. Exposure: Body fluid biomarkers and environmental factors in pwRIS. Main outcomes and measures: The main outcome was the development of MS symptoms. Analyses involved univariable and multivariable Cox proportional hazards models, including age, sex, and treatment following RIS diagnosis, as additional independent variables. Results: The study included 273 pwRIS (mean age, 38.6 [SD 11.6] years; 207 women [75.8%] and 66 men [24.2%]) with a median follow-up of 5.0 [IQR, 2.5-7.7] years. A total of 101 pwRIS developed MS symptoms (37.0%). The presence of immunoglobulin G oligoclonal bands (OBs) (hazard ratio [HR], 5.09; 95% CI, 2.36-10.97; P < .001), immunoglobulin M OBs (HR, 2.58; 95% CI, 1.61-4.14; P < .001), and a κ free light chain index of 6.1 or more (HR, 2.79; 95% CI, 1.37-5.67; P = .005) were associated with MS symptoms. High cerebrospinal fluid neurofilament light chain (NfL) levels (HR, 1.31; 95% CI, 1.18-1.45; P < .001) and high serum NfL z scores (HR, 1.42; 95% CI, 1.16-1.72; P = .005) were also associated with an increased risk of MS symptoms. In contrast, high anti-cytomegalovirus titers (HR, 0.59; 95% CI, 0.38-0.93; P = .02) and high ultraviolet radiation exposure in the year before (HR, 0.52; 95% CI, 0.37-0.74; P < .001) and the year after (HR, 0.54, 95% CI, 0.38-0.75; P < .001) diagnosis reduced the risk of MS symptoms. For all these prognostic factors, the multivariable analysis yielded similar results. The combination of high serum NfL z scores and positive immunoglobulin G OBs conferred a 5-year risk of clinical symptoms of 58.3% (95% CI, 45.9-67.9). This risk increased to 81.6% (95% CI, 60.9-91.4) in pwRIS who were younger and positive for immunoglobulin M OBs. Conclusions and Relevance: The study elucidates the prognostic factors that significantly impact the risk of developing MS symptoms in pwRIS at diagnosis, thereby, enhancing the potential for tailored clinical interventions.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.054
GPT teacher head0.299
Teacher spread0.246 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJAMA NeurologySame topicMultiple Sclerosis Research StudiesFrench-language works237,207